Applied DNA Sciences (NASDAQ:APDN – Get Free Report) had its price target cut by equities researchers at HC Wainwright from $2.00 to $1.50 in a research report issued on Friday, Benzinga reports. The brokerage currently has a “buy” rating on the technology company’s stock. HC Wainwright’s price objective suggests a potential upside of 154.24% from […]